4//SEC Filing
Ren Ken Keyong 4
Accession 0001144204-19-004172
CIK 0000895051other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 7:21 PM ET
Size
5.7 KB
Accession
0001144204-19-004172
Insider Transaction Report
Form 4
Ren Ken Keyong
Chief Executive Officer
Transactions
- Award
Stock Options (Right to Buy)
2019-01-29+75,000→ 75,000 totalExercise: $0.88From: 2019-01-29Exp: 2026-03-02→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]On March 2, 2016, the reporting person was granted an option to purchase shares of common stock that would vest upon achievement of certain performance based conditions. On January 29, 2019, the Compensation Committee certified that the performance based condition relating to the vesting of 75,000 options had been satisfied on October 18, 2018, resulting in vesting of the options.
Documents
Issuer
CASI Pharmaceuticals, Inc.
CIK 0000895051
Entity typeother
Related Parties
1- filerCIK 0001545181
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 7:21 PM ET
- Size
- 5.7 KB